Description of pharmacist interventions during physician–pharmacist co-management of hypertension

Muenster, Shannon J. Von; Carter, Barry L.; Weber, Cynthia A.; Ernst, Michael E.; Milchak, Jessica L.; Steffensmeier, Jennifer J. G.; Xu, Yinghui

doi:10.1007/s11096-007-9155-6

Cited by 77 publications

(96 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The vast majority of changes occurred in the first 2 months of the intervention and dose titrations usually occurred every 2 to 4 weeks. 12 Thus, our study clearly demonstrated that high BP control rates, including in patients with diabetes, can be achieved without FDCs.…”

supporting

confidence: 56%

“…14 The 2 most effective strategies that were used in our Collaborative Management of Hypertension study 11 for patients with previously uncontrolled hypertension was to switch to chlorthalidone or add low-dose spironolactone even in patients already taking a CCB plus an ACEI or ARB. 12 The need for such add-on therapy greatly limits the presumed simplicity of the FDC.…”

Section: Could Fdcs Lead To Irrational Choices or Switching?mentioning

confidence: 99%

See 1 more Smart Citation

Fixed‐Dosed Combinations Are Not Indicated as Initial Therapy: A Debate

Carter

2009

J of Clinical Hypertension

Self Cite

View full text Add to dashboard Cite

supporting

confidence: 56%

Section: Could Fdcs Lead To Irrational Choices or Switching?mentioning

confidence: 99%

Fixed‐Dosed Combinations Are Not Indicated as Initial Therapy: A Debate

Carter

2009

J of Clinical Hypertension

Self Cite

View full text Add to dashboard Cite

“…This rate was similar to rates seen in programs where pharmacists were not integrated into the prescriber teams 16,27,28 and was much lower than rates documented in other settings, where the pharmacist was part of the prescriberbased team. 6,29,30 If this service were to become permanent, a concentrated effort to engage prescribers from the beginning would be crucial. Trust is a significant component of functional, collaborative working relationships, but without time and repeated interactions, trust between physicians and pharmacists cannot develop.…”

Section: Discussionmentioning

confidence: 99%

Impact of Pharmacists in a Community-Based Home Care Service: A Pilot Program

Walus

Woloschuk

2017

CJHP

View full text Add to dashboard Cite

Background: Historically, pharmacists have not been included on home care teams, despite the fact that home care patients frequently experience medication errors. Literature describing Canadian models of pharmacy practice in home care settings is limited. The optimal service delivery model and distribution of clinical activities for home care pharmacists remain unclear. Objectives: The primary objective was to describe the impact of a pharmacist based at a community home care office and providing home visits, group education, and telephone consultations. The secondary objective was to determine the utility of acute care clinical pharmacy key performance indicators (cpKPIs) in guiding home care pharmacy services, in the absence of validated cpKPIs for ambulatory care. Methods: The Winnipeg Regional Health Authority hired a pharmacist to develop and implement the pilot program from May 2015 to July 2016. A referral form, consisting of consultation criteria used in primary care practices, was developed. The pharmacist also reviewed all patient intakes and all patients waiting in acute care facilities for initiation of home care services, with the goal of addressing issues before admission to the Home Care Program. A password-protected database was built for data collection and analysis, and the data are presented in aggregate. Results: A total of 197 referrals, involving 184 patients, were received during the pilot program; of these, 62 were excluded from analysis. The majority of referrals (95 [70.4%]) were for targeted medication reviews, and 271 drug therapy problems were identified. Acceptance rates for the pharmacist's recommendations were 90.2% (74 of 82 recommendations) among home care staff and 47.0% (55 of 117 recommendations) among prescribers and patients. On average, 1.5 cpKPIs were identified for each referral. Conclusions:The pilot program demonstrated a need for enhanced access to clinical pharmacy services for home care patients, although the best model of service provision remains unclear. More research is warranted to determine the optimal pharmacy service for home care patients and the most appropriate cpKPIs to measure its effects.

show abstract

“…Previous studies have demonstrated that pharmacists are well suited to provide support, able to create effective relationships with providers and achieve high provider acceptance of pharmacist recommendations [24,25]. Furthermore, pharmacists have successful providers in patient-centered medical homes [26] and have provided care with demonstrated improved patient outcomes [27][28][29].…”

mentioning

confidence: 99%

Primary Care Providers’ Use of Pharmacist Support for Delivery of Pharmacogenetic Testing

et al. 2017

View full text Add to dashboard Cite

Aim. To investigate provider utilization of pharmacist support in the delivery of pharmacogenetic testing in a primary care setting. Methods. Two primary care clinics within Duke University Health System participated in the study between December 2012 and July 2013. One clinic was provided with an in-house pharmacist and the second clinic had an on-call pharmacist. Results: Providers in the in-house pharmacist arm consulted with the pharmacist for 13 of 15 cases, or about one of every four patients tested compared with one of every 7.5 patients in the on-call pharmacist arm. A total of 63 tests were ordered, 48 by providers in the pharmacist-in-house arm. Conclusion: These findings suggest that the availability of an in-house pharmacist increases the likelihood of pharmacogenetic test utilization.

show abstract

Description of pharmacist interventions during physician–pharmacist co-management of hypertension

Cited by 77 publications

References 44 publications

Fixed‐Dosed Combinations Are Not Indicated as Initial Therapy: A Debate

Fixed‐Dosed Combinations Are Not Indicated as Initial Therapy: A Debate

Impact of Pharmacists in a Community-Based Home Care Service: A Pilot Program

Primary Care Providers’ Use of Pharmacist Support for Delivery of Pharmacogenetic Testing

Contact Info

Product

Resources

About